Study Protocol for the Pleiotropic Effects of Sodium-Glucose Cotransporter 2 Inhibitor on Organ-Specific Sympathetic Nerve Activity and Insulin Sensitivity in Participants with Type 2 Diabetes.

Yumie TakeshitaChiaki NomuraHisayoshi MuraiYusuke MukaiTadayuki HiraiTakuto HamaokaShota TokunoTakeo TanakaHisanori GotoYujiro NakanoSoichiro UsuiKenichi NakajimaMasayuki TakamuraToshinari Takamura

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)

The study protocol has been approved by the Certified Review Board, Kanazawa University, Ishikawa, Japan, in accordance with the guidelines stipulated in the Declaration of Helsinki (CRB4180005, 2019-001). This trial is registered with the Japan Registry of Clinical Trials, jRCTs 041200035.

Keyphrases

clinical trial
study protocol
phase ii
phase iii
randomized controlled trial
open label
double blind
clinical practice
peripheral nerve
placebo controlled